Tests a nerve block procedure for chronic migraine in adults
Tests a nerve block procedure in adults with chronic migraine.
Plain-language title generated from the registry record
Registry title: Ultrasound-guided Stellate Ganglion Block for Treatment of Chronic Migraine in Adult
Key facts
- Where
- Beijing, ChinaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Source: NCT06322407, who can take part
Where in China
- Beijing Tiantan HospitalBeijing, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Beijing Tiantan Hospital
- Trial code
- NCT06322407
- Record updated
- 17 January 2025
- Original description
To assess the 6-months effects and safety of stellate ganglion block(SGB) for Chronic Migraine (CM) patients who failure to undergo preventive therapy and are seeking a more suitable non-pharmacological therapy.Read full original descriptionShow less
A Prospective, Randomized, Controlled, Blinded-endpoint Study to Evaluate the Efficacy and Safety of Stellate Ganglion Block for CM Treatment
To assess the 6-months effects and safety of stellate ganglion block(SGB) for Chronic Migraine (CM) patients who failure to undergo preventive therapy and are seeking a more suitable non-pharmacological therapy.
Inclusion: Age from 18 to 65 years; Diagnosed with CM according to the International Classification of Headache Disorders, 3rd (ICHD-3) criteria [Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38:1-211]; not received prior prophylactic migraine treatment or, due to lack of efficacy or tolerability, had failed or had not been suitable for up to three previous prophylactic treatments from the following: Metoprolol/propranolol, amitriptyline, and flunarizine.
Exclusion: Previous SGB treatment；; Neck anatomic structural changes (caused by radiotherapy or surgery); History of other neurological disorders；; History of severe cardiopulmonary, hepatic or renal dysfunction；; History of allergies to any of the study drugs；; Infection or mass near the puncture site；; Psychological disorders; BMI <15 kg/m2 or >35 kg/m2；; Patients with chronic use of opioids；; Preoperative coagulation abnormalities (activated partial thromboplastin time greater than 1.5 time normal value)；; Pregnant or breast feeding; Refusal to sign informed consent.